Actavis To Offer $8.4B In Shares To Fund Allergan Takeover
Actavis PLC said Thursday it plans to sell $8.4 billion in shares in two public offerings to fund its blockbuster acquisition of Allergan Inc. that will vault the Irish drugmaker to...To view the full article, register now.
Already a subscriber? Click here to view full article